Driven by a powerful platform combining computational biology and artificial intelligence, Adagene creates novel antibodies that overcome safety issues and improve efficacy to bring hope to more cancer patients. Its discovery engine, Dynamic Precision Library, is driving Adagene’s pipeline of programs with potential to be first or best in class.
The company has forged strategic partnerships with multiple reputable global companies. These partnerships leverage its technology in approaches at the vanguard of science, including safer precision-guided antibody-drug conjugates and transformative antibody design.
The company has forged strategic partnerships with multiple reputable global companies. These partnerships leverage its technology in approaches at the vanguard of science, including safer precision-guided antibody-drug conjugates and transformative antibody design.